These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

176 related items for PubMed ID: 3829675

  • 1. A multi-compartment vaginal ring system for independently adjustable release of contraceptive steroids.
    de Leede LG, Govers CP, de Nijs H.
    Contraception; 1986 Dec; 34(6):589-602. PubMed ID: 3829675
    [Abstract] [Full Text] [Related]

  • 2. Pharmacokinetics of 3-keto-desogestrel and ethinylestradiol released from different types of contraceptive vaginal rings.
    Timmer CJ, Apter D, Voortman G.
    Contraception; 1990 Dec; 42(6):629-42. PubMed ID: 2150632
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Comparative study on the efficacy and acceptability of two contraceptive pills administered by the vaginal route: an international multicenter clinical trial.
    Coutinho EM, de Souza JC, da Silva AR, de Acosta OM, Alvarez F, Brache V, Garza Flores J, Vasquez-Estrada L, Santo R, Bassol S.
    Clin Pharmacol Ther; 1993 Jan; 53(1):65-75. PubMed ID: 8422744
    [Abstract] [Full Text] [Related]

  • 7. [Vaginal contraception with steroids].
    Levrier M.
    Contracept Fertil Sex (Paris); 1993 Nov; 21(11):837-8. PubMed ID: 12287400
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Oral contraceptives containing 20 or 30 micrograms ethinylestradiol and 150 micrograms desogestrel: pharmacokinetics and pharmacodynamic parameters.
    Jung-Hoffmann C, Fitzner M, Kuhl H.
    Horm Res; 1991 Nov; 36(5-6):238-46. PubMed ID: 1823082
    [Abstract] [Full Text] [Related]

  • 11. Analysis and new contraception frontiers with combined vaginal rings.
    Barriga Pooley P, Von Hoveling A, Galán G, López Berroa J.
    Gynecol Endocrinol; 2020 Jun; 36(6):475-478. PubMed ID: 32091277
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical and metabolic study of a new pill containing 20 mcg ethinylestradiol plus 0.150 mg desogestrel.
    Fioretti P, Fruzzetti F, Navalesi R, Ricci C, Miccoli R, Cerri M, Orlandi MC, Melis GB.
    Contraception; 1987 Mar; 35(3):229-43. PubMed ID: 2956055
    [Abstract] [Full Text] [Related]

  • 14. Residual hormone levels in used contraceptive rings as a measurement of adherence to vaginal ring use.
    Haaland RE, Holder A, Evans-Strickfaden T, Nyagol B, Makanga M, Oyaro B, Humwa F, Williams T, McLellan-Lemal E, Desai M, Huey MJ.
    Contraception; 2017 Jun; 95(6):602-604. PubMed ID: 28372978
    [Abstract] [Full Text] [Related]

  • 15. Pharmacodynamics of a contraceptive vaginal ring releasing 3-keto-desogestrel.
    Jackson R, Newton JR.
    Contraception; 1989 Jun; 39(6):653-64. PubMed ID: 2752753
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Plasma concentrations of 3-keto-desogestrel after oral administration of desogestrel and intravenous administration of 3-keto-desogestrel.
    Back DJ, Grimmer SF, Shenoy N, Orme ML.
    Contraception; 1987 Jun; 35(6):619-26. PubMed ID: 2959449
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.